To determine the role of ERα in cadmium-induced breast cancer progression, we used the CRISPR/Cas9 gene editing system to permanently knock out ERα expression in parental MCF7 cells and two previously established cadmium-adapted MCF7 clonal cell lines (Cd7 and Cd12)16. The gene discussed is ESR1; the disease is breast carcinoma.